Rethinking newborn screening for critical congenital heart disease

Critical congenital heart diseases, or CCHDs, are a group of life-threatening structural heart defects present at birth.
Hosted on MSN

Masimo study shows equitable accuracy in newborn oxygen monitoring

Masimo's NeoPODS study found its SET pulse oximetry technology delivered consistent accuracy in critically ill newborns across all skin tones, addressing longstanding concerns over racial bias in ...
Hosted on MSN

NeoPODS study finds Masimo SET accurate across skin tones

Masimo’s NeoPODS study in critically ill newborns found its SET pulse oximetry technology delivered consistent accuracy across all skin tones, with less than 1% bias. The findings address longstanding ...
MassDevice

Masimo reports positive findings for pulse oximetry in hospitalized newborns of all skin tones

Masimo (Nasdaq:MASI) today announced new study findings supporting the use of its SET pulse oximetry in critically ill neonates.
Medscape

Congenital Heart Disease Screening in Newborns

Thangaratinam and colleagues aimed to shed light on the potential predictive value of using pulse oximetry to screen for significant cyanotic congenital heart disease (CHD) in newborn infants. One ...